|

GEH200520 Injection / GEH200521 (18F) Injection - Part A Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • GE Healthcare1

Indications

  • Malignant Solid Tumor1
  • Oncology1
  • Cancer1

Other1 trial

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.